UNSPSC 51171727: Eluxadoline

A mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowelsyndrome with diarrhea.

UNSPSC 51171727 Eluxadoline is a Commodity code for a specific pharmaceutical product, but recent state and local procurement activity tagged under this code does not reflect purchases of eluxadoline itself. Instead, the tagged opportunities center on drug testing services, direct-to-manufacturer pharmacy programs, and generic multi-source pharmaceutical supply contracts. The mismatch suggests that either the code assignment in these solicitations is incorrect or that the code is used as a placeholder for broader pharmaceutical procurement activities. State and local governments are soliciting pharmaceutical supply agreements and specialty testing services under this tag, with issuing bodies including county criminal justice departments, state health and human services commissions, and multi-state cooperative purchasing alliances. The work being solicited encompasses specimen collection and drug testing (immunoassay and confirmatory LC/MS/MS or GC/MS screening), direct contracting between state pharmacy benefit programs and manufacturers outside traditional pharmacy benefit manager and group purchasing organization channels, and supply of generic and over-the-counter pharmaceuticals through authorized wholesale distributors.

Recent opportunities span Texas and Minnesota, with activity driven by Collin County Community Supervision and Corrections Department (RFP 2026-327 for offender drug testing due July 23, 2026, estimated contract value $600,000), the Texas Health and Human Services Commission (RFI HHS0017013 for direct-to-manufacturer prescription capabilities, posted April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance (RFP S1070000015802 for generic pharmaceuticals and OTC products due March 26, 2026). The Collin County opportunity involves staffing two collection sites and operating an interactive voice response system for approximately 25,031 annual tests across five-panel and six-panel screens, with a two-year contract term and optional renewals not exceeding five years. The MMCAP procurement seeks manufacturers to supply products through three authorized wholesalers with pricing effective July 1, 2026, and evaluation weighted 75 percent on price competitiveness. No recent opportunities confirm demand for eluxadoline specifically under this code.